HB 61 is sponsored by Debra Heffernan (Democratic), Nnamdi O. Chukwuocha (Democratic), Bryan Townsend (Democratic), Nicole Poore (Democratic), Brian Pettyjohn (Republican), Stephanie L. Hansen (Democratic), John "Jack" Walsh, Paul S. Baumbach, Ernesto B Lopez, Ruth Briggs King, David Bentz, John A. Kowalko, and Raymond Seigfried.

Where can I track HB 61?

Track HB 61 free on One Click Politics — get push/email alerts when it moves.

Delaware 150th General Assembly (2019-2020) Status: Enacted Bipartisan · 5 D · 1 R cosponsors

HB 61 — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.

Last action June 19, 2019 — Signed by Governor

✓
Introduced
✓
In Committee
✓
Passed House
✓
Passed Senate
✓
To Executive
6
Enacted

This bill has been enacted into law. Introduced February 28, 2019. Enacted.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 98% · high confidence

Enacted

Current position in the legislative process.
13 sponsors

4 primary, 9 co-sponsors signed on.
Bipartisan support

Sponsored across 2 parties (5 D · 1 R) — cross-party backing.
Cleared a recorded vote

Passed 2 recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Benzodiazepine drugs that are approved for medical use in the United States are classified by the federal Drug Enforcement Agency as Schedule IV. Fourteen benzodiazepine drugs are currently listed on Schedule IV of the Uniform Controlled Substances Act, § 4720 of Title 16. Benzodiazepine drugs have a serious potential for abuse. This Act adds both additional benzodiazepine drugs by name and the category of benzodiazepine drugs to Schedule IV of the Uniform Controlled Substances Act so that all current and future benzodiazepine drugs are included on Schedule IV in Delaware, whether or not the specific drug is approved for medical use in the United States.

Bill Text

Bill Text View text Current pdf

Action History

June 19, 2019
Signed by Governor
April 09, 2019
Passed By Senate. Votes: 21 YES
March 27, 2019
Reported Out of Committee (Health & Social Services) in Senate with 3 On Its Merits
March 19, 2019
Assigned to Health & Social Services Committee in Senate
March 19, 2019
Passed By House. Votes: 40 YES 1 ABSENT
March 06, 2019
Reported Out of Committee (Health & Human Development) in House with 10 On Its Merits
February 28, 2019
Introduced and Assigned to Health & Human Development Committee in House

Sponsorship breakdown

Export CSV (upgrade) →

4 sponsors · 9 co-sponsors · 49 not signed on

Sponsors (4)

Co-sponsors (9)

Not signed on (49)

49 members have not signed on to this bill.

Show all 49 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

SM

April 09, 2019

Passed 21 Yea · 0 Nay

Party	Yea	Nay	Present	Not Voting
Unaffiliated	7	0	0	0
Democratic	9	0	0	0
Republican	5	0	0	0
Total	21	0	0	0
% of votes cast	100%	0%	0%	0%

How each member voted (21)

Member	Party	Vote
Anthony Delcollo	—	Yea
Bruce C. Ennis	—	Yea
Catherine Cloutier	—	Yea
Colin Bonini	—	Yea
David B. McBride	—	Yea
Ernesto B Lopez	—	Yea
Harris B. McDowell	—	Yea
Bryan Townsend	Democratic	Yea
Darius J. Brown	Democratic	Yea
David P. Sokola	Democratic	Yea
John "Jack" Walsh	Democratic	Yea
Laura V. Sturgeon	Democratic	Yea
Nicole Poore	Democratic	Yea
S. Elizabeth Lockman	Democratic	Yea
Stephanie L. Hansen	Democratic	Yea
Trey Paradee	Democratic	Yea
Brian Pettyjohn	Republican	Yea
Bryant L. Richardson	Republican	Yea
Dave G. Lawson	Republican	Yea
David L. Wilson	Republican	Yea
Gerald W. Hocker	Republican	Yea

Official roll call →

SM

March 19, 2019

Passed 40 Yea · 0 Nay · 1 Other

Party	Yea	Nay	Present	Not Voting
Unaffiliated	16	0	0	1
Democratic	12	0	0	0
Republican	12	0	0	0
Total	40	0	0	1
% of votes cast	98%	0%	0%	2%

How each member voted (41)

Member	Party	Vote
Andria L. Bennett	—	Yea
David Bentz	—	Yea
Earl G. Jaques Jr.	—	Yea
Gerald L. Brady	—	Yea
John A. Kowalko	—	Yea
John J. Viola	—	Yea
John L. Mitchell	—	Yea
Michael Ramone	—	Yea
Paul S. Baumbach	—	Yea
Peter C. Schwartzkopf	—	Yea
Quinton Johnson	—	Yea
Raymond Seigfried	—	Yea
Ruth Briggs King	—	Yea
Sean Matthews	—	Not Voting
Sherry Dorsey Walker	—	Yea
Stephen Smyk	—	Yea
Valerie Longhurst	—	Yea
Debra Heffernan	Democratic	Yea
Edward S. Osienski	Democratic	Yea
Franklin D. Cooke	Democratic	Yea
Kendra Johnson	Democratic	Yea
Kimberly Williams	Democratic	Yea
Krista Griffith	Democratic	Yea
Melissa Minor-Brown	Democratic	Yea
Nnamdi O. Chukwuocha	Democratic	Yea
Sean M. Lynn	Democratic	Yea
Stephanie T. Bolden	Democratic	Yea
William Bush	Democratic	Yea
William J. Carson	Democratic	Yea
Bryan W. Shupe	Republican	Yea
Charles S Postles Jr.	Republican	Yea
Daniel B. Short	Republican	Yea
Jeffrey N. Spiegelman	Republican	Yea
Jesse R. Vanderwende	Republican	Yea
Kevin S Hensley	Republican	Yea
Lyndon D. Yearick	Republican	Yea
Michael F. Smith	Republican	Yea
Richard G. Collins	Republican	Yea
Ronald E. Gray	Republican	Yea
Shannon Morris	Republican	Yea
Timothy D. Dukes	Republican	Yea

Official roll call →

Subjects

public-safety healthcare

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 61 do?: Benzodiazepine drugs that are approved for medical use in the United States are classified by the federal Drug Enforcement Agency as Schedule IV. Fourteen benzodiazepine drugs are currently listed on Schedule IV of the Uniform Controlled Substances Act, § 4720 of Title 16. Benzodiazepine drugs have a serious potential for abuse. This Act adds both additional benzodiazepine drugs by name and the category of benzodiazepine drugs to Schedule IV of the Uniform Controlled Substances Act so that all current and future benzodiazepine drugs are included on Schedule IV in Delaware, whether or not the specific drug is approved for medical use in the United States.
Who sponsors HB 61?: HB 61 is sponsored by Debra Heffernan (Democratic), Nnamdi O. Chukwuocha (Democratic), Bryan Townsend (Democratic), Nicole Poore (Democratic), Brian Pettyjohn (Republican), Stephanie L. Hansen (Democratic), John "Jack" Walsh, Paul S. Baumbach, Ernesto B Lopez, Ruth Briggs King, David Bentz, John A. Kowalko, and Raymond Seigfried.
What is the current status of HB 61?: This bill has been enacted into law. Introduced February 28, 2019. Enacted.
Where can I track HB 61?: Track HB 61 free on One Click Politics — get push/email alerts when it moves.

Keep track of this bill

Add this bill to your alerts and we'll email you when it moves — or keep it on a watchlist and see it in your weekly digest.

Create a free account →

At a glance

Identifier: HB 61
Jurisdiction: Delaware
Session: 150th General Assembly (2019-2020)
Type: Bill
Introduced: February 28, 2019
Status: Enacted
Prime sponsor: John "Jack" Walsh

Make your voice heard on HB 61

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 61

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →